GSK severe asthma drug progresses to Phase III – InPharm
InPharmGSK severe asthma drug progresses to Phase IIIInPharmThe year-long study, which involved 621 patients, found the number of clinically significant exacerbations in patients on GSK's drug – that is defined as episodes requiring oral corticos…
